System Transmission

Top Signal

100#1 JOB

Activity

2185Ripe

+943 today

System

Livenow

Terminal Asset View

stockNASDAQ

ACET

$7.21+2.41%

Adicet Bio Inc. - Common Stock

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

75Ripe

Live Analysis Active

Company Mission

Adicet Bio develops cell therapies that use a patient's own immune cells to fight cancer. The company engineers these cells to recognize and attack cancer cells more effectively. It makes money through research partnerships with pharmaceutical companies and could earn revenue from future drug sales if its treatments receive regulatory approval.

ACE

Industry Context

The biotechnology industry focuses on developing medical treatments using living organisms and biological systems. Companies in this space often experience significant price swings based on clinical trial results, regulatory approvals, and partnership announcements. Cell therapy represents an innovative approach within biotech that's gaining attention for its potential to treat difficult diseases.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

87Matrix

Market Momentum

48.3— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

2.41%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ACET across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:22 AM UTC

As-of 03-15-2026 03:07 UTC

Develops cancer treatments using engineered immune cells and makes money by partnering with pharmaceutical companies to advance these therapies.

Price consolidating near recent lows after a 6% drop over three days, suggesting energy building for the next directional move.

Biotech sector showing volatility as investors weigh clinical trial results, creating opportunities for companies with novel approaches like cell,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...